
OncoCyte Corp (OCX) - Product Pipeline Analysis, 2023 Update
Description
South America Flat Glass Market Summary, Competitive Analysis and Forecast to 2027
Summary
Flat Glass in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. By end-use, the market is segmented into building & construction, automotive, and others. The scope of others segment includes electronics, solar PV, and furniture.
- The South American flat glass market had total revenues of $2.9 billion in 2022, representing a compound annual growth rate (CAGR) of 3.9% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 3.2% between 2017 and 2022, to reach a total of 4.4 million Tons in 2022.
- South America has a share of 2.6% in the global flat glass market. For windows, glass doors, transparent walls, and windscreens, flat glass is a type of glass that was initially created in plane shape.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the flat glass market in South America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the flat glass market in South America
- Leading company profiles reveal details of key flat glass market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South America flat glass market with five year forecasts
- What was the size of the South America flat glass market by value in 2022?
- What will be the size of the South America flat glass market in 2027?
- What factors are affecting the strength of competition in the South America flat glass market?
- How has the market performed over the last five years?
- What are the main segments that make up South America's flat glass market?
Table of Contents
77 Pages
- OncoCyte Corp Company Overview
- OncoCyte Corp Company Snapshot
- OncoCyte Corp Pipeline Products and Ongoing Clinical Trials Overview
- OncoCyte Corp – Pipeline Analysis Overview
- OncoCyte Corp - Key Facts
- OncoCyte Corp - Major Products and Services
- OncoCyte Corp Pipeline Products by Development Stage
- OncoCyte Corp Ongoing Clinical Trials by Trial Status
- OncoCyte Corp Pipeline Products Overview
- ALK Resistance Monitoring Assay
- ALK Resistance Monitoring Assay Product Overview
- Breast Confirmatory BI RADS 3-4 Assay
- Breast Confirmatory BI RADS 3-4 Assay Product Overview
- Companion Diagnostic Test - Alzheimer’s Disease
- Companion Diagnostic Test - Alzheimer’s Disease Product Overview
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis
- Companion Diagnostic Test - Amyotrophic Lateral Sclerosis Product Overview
- Companion Diagnostic Test - Breast Cancer
- Companion Diagnostic Test - Breast Cancer Product Overview
- Companion Diagnostic Test - Chronic Fatigue Syndrome
- Companion Diagnostic Test - Chronic Fatigue Syndrome Product Overview
- Companion Diagnostic Test - Colorectal Cancer
- Companion Diagnostic Test - Colorectal Cancer Product Overview
- Companion Diagnostic Test - Multiple Sclerosis
- Companion Diagnostic Test - Multiple Sclerosis Product Overview
- Companion Diagnostic Test - Parkinson’s Disease
- Companion Diagnostic Test - Parkinson’s Disease Product Overview
- Companion Diagnostic Test - Prostate Cancer
- Companion Diagnostic Test - Prostate Cancer Product Overview
- Companion Diagnostic Test - Rheumatoid Arthritis
- Companion Diagnostic Test - Rheumatoid Arthritis Product Overview
- Dense Breast Tissue Confirmatory Test - Breast Cancer
- Dense Breast Tissue Confirmatory Test - Breast Cancer Product Overview
- DetermaCNI
- DetermaCNI Product Overview
- DetermaDx
- DetermaDx Product Overview
- DetermaIO
- DetermaIO Product Overview
- DetermaIO Clinical Trial
- DetermaMX
- DetermaMX Product Overview
- DetermaTx
- DetermaTx Product Overview
- Diagnostic Assay - Amyloidosis
- Diagnostic Assay - Amyloidosis Product Overview
- Diagnostic Assay - Autism Spectrum Disorder
- Diagnostic Assay - Autism Spectrum Disorder Product Overview
- Diagnostic Assay - HPV
- Diagnostic Assay - HPV Product Overview
- Diagnostic Assay - Type I Diabetes
- Diagnostic Assay - Type I Diabetes Product Overview
- Diagnostic Test - Brain Cancer
- Diagnostic Test - Brain Cancer Product Overview
- Diagnostic Test - Gulf War Illnesses
- Diagnostic Test - Gulf War Illnesses Product Overview
- Diagnostic Test - Huntington's Disease
- Diagnostic Test - Huntington's Disease Product Overview
- Diagnostic Test - Lung Cancer
- Diagnostic Test - Lung Cancer Product Overview
- Diagnostic Test - Ovarian Cancer
- Diagnostic Test - Ovarian Cancer Product Overview
- Diagnostic Test - Systemic Lupus Erythematous
- Diagnostic Test - Systemic Lupus Erythematous Product Overview
- Insight ALK ECD Assay
- Insight ALK ECD Assay Product Overview
- Insight DEPDC1 Screen Assay
- Insight DEPDC1 Screen Assay Product Overview
- Insight ROS1 Fusion Screen Assay
- Insight ROS1 Fusion Screen Assay Product Overview
- KIR/KIR-Ligand LDT Assay
- KIR/KIR-Ligand LDT Assay Product Overview
- Lung Screening Assay
- Lung Screening Assay Product Overview
- Next-Generation DetermaVu
- Next-Generation DetermaVu Product Overview
- NGS Lung Panel Test
- NGS Lung Panel Test Product Overview
- PanC-Dx - Bladder Cancer
- PanC-Dx - Bladder Cancer Product Overview
- PanC-Dx - Breast Cancer
- PanC-Dx - Breast Cancer Product Overview
- PanC-Dx - Breast Cancer Clinical Trial
- PanC-Dx - Colon Cancer
- PanC-Dx - Colon Cancer Product Overview
- PanC-Dx - Lung Cancer
- PanC-Dx - Lung Cancer Product Overview
- PanC-Dx - Prostate Cancer
- PanC-Dx - Prostate Cancer Product Overview
- Therapeutic Monitoring Test - Pancreatic Cancer
- Therapeutic Monitoring Test - Pancreatic Cancer Product Overview
- Therasure Transplant Monitor Test - LDT
- Therasure Transplant Monitor Test - LDT Product Overview
- Tumor Type 4 Assay
- Tumor Type 4 Assay Product Overview
- OncoCyte Corp - Key Competitors
- OncoCyte Corp - Key Employees
- OncoCyte Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- OncoCyte Corp, Recent Developments
- Mar 31, 2023: Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K
- Mar 29, 2023: Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
- Mar 02, 2023: Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
- Nov 30, 2022: Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors
- Nov 30, 2022: Oncocyte Announces Executive Leadership Changes
- Nov 10, 2022: Oncocyte Reports Third Quarter 2022 Financial Results
- Aug 31, 2022: Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference
- Mar 28, 2022: Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022
- Mar 10, 2022: Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
- Nov 09, 2021: Oncocyte Reports Third Quarter 2021 Financial Results and Provides Corporate Update
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: OncoCyte Corp Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: OncoCyte Corp Pipeline Products by Equipment Type
- Table 3: OncoCyte Corp Pipeline Products by Indication
- Table 4: OncoCyte Corp, Key Facts
- Table 5: OncoCyte Corp, Major Products and Services
- Table 6: OncoCyte Corp Number of Pipeline Products by Development Stage
- Table 7: OncoCyte Corp Pipeline Products Summary by Development Stage
- Table 8: OncoCyte Corp Ongoing Clinical Trials by Trial Status
- Table 9: OncoCyte Corp Ongoing Clinical Trials Summary
- Table 10: ALK Resistance Monitoring Assay - Product Status
- Table 11: ALK Resistance Monitoring Assay - Product Description
- Table 12: Breast Confirmatory BI RADS 3-4 Assay - Product Status
- Table 13: Breast Confirmatory BI RADS 3-4 Assay - Product Description
- Table 14: Companion Diagnostic Test - Alzheimer’s Disease - Product Status
- Table 15: Companion Diagnostic Test - Alzheimer’s Disease - Product Description
- Table 16: Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status
- Table 17: Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Description
- Table 18: Companion Diagnostic Test - Breast Cancer - Product Status
- Table 19: Companion Diagnostic Test - Breast Cancer - Product Description
- Table 20: Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Status
- Table 21: Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Description
- Table 22: Companion Diagnostic Test - Colorectal Cancer - Product Status
- Table 23: Companion Diagnostic Test - Colorectal Cancer - Product Description
- Table 24: Companion Diagnostic Test - Multiple Sclerosis - Product Status
- Table 25: Companion Diagnostic Test - Multiple Sclerosis - Product Description
- Table 26: Companion Diagnostic Test - Parkinson’s Disease - Product Status
- Table 27: Companion Diagnostic Test - Parkinson’s Disease - Product Description
- Table 28: Companion Diagnostic Test - Prostate Cancer - Product Status
- Table 29: Companion Diagnostic Test - Prostate Cancer - Product Description
- Table 30: Companion Diagnostic Test - Rheumatoid Arthritis - Product Status
- Table 31: Companion Diagnostic Test - Rheumatoid Arthritis - Product Description
- Table 32: Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Status
- Table 33: Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Description
- Table 34: DetermaCNI - Product Status
- Table 35: DetermaCNI - Product Description
- Table 36: DetermaDx - Product Status
- Table 37: DetermaDx - Product Description
- Table 38: DetermaIO - Product Status
- Table 39: DetermaIO - Product Description
- Table 40: DetermaIO - A Randomized, Phase Iii Trial to Evaluate the Efficacy and Safety of Pembrolizumab (Mk-3475) as Adjuvant Therapy for Triple Receptor-negative Breast Cancer with ≫/= 1 Cm Residual Invasive Cancer or Positive Lymph Nodes (Ypn1mi, Ypn1-3) after Neoadjuvant Chemotherapy
- Table 41: DetermaIO - Neo-adjuvant Study with the PDL1-directed Antibody in Triple Negative Locally Advanced Breast Cancer Undergoing Treatment with Nab-paclitaxel and Carboplatin
- Table 42: DetermaMX - Product Status
- Table 43: DetermaMX - Product Description
- Table 44: DetermaTx - Product Status
- Table 45: DetermaTx - Product Description
- Table 46: Diagnostic Assay - Amyloidosis - Product Status
- Table 47: Diagnostic Assay - Amyloidosis - Product Description
- Table 48: Diagnostic Assay - Autism Spectrum Disorder - Product Status
- Table 49: Diagnostic Assay - Autism Spectrum Disorder - Product Description
- Table 50: Diagnostic Assay - HPV - Product Status
- Table 51: Diagnostic Assay - HPV - Product Description
- Table 52: Diagnostic Assay - Type I Diabetes - Product Status
- Table 53: Diagnostic Assay - Type I Diabetes - Product Description
- Table 54: Diagnostic Test - Brain Cancer - Product Status
- Table 55: Diagnostic Test - Brain Cancer - Product Description
- Table 56: Diagnostic Test - Gulf War Illnesses - Product Status
- Table 57: Diagnostic Test - Gulf War Illnesses - Product Description
- Table 58: Diagnostic Test - Huntington's Disease - Product Status
- Table 59: Diagnostic Test - Huntington's Disease - Product Description
- Table 60: Diagnostic Test - Lung Cancer - Product Status
- Table 61: Diagnostic Test - Lung Cancer - Product Description
- Table 62: Diagnostic Test - Ovarian Cancer - Product Status
- Table 63: Diagnostic Test - Ovarian Cancer - Product Description
- Table 64: Diagnostic Test - Systemic Lupus Erythematous - Product Status
- Table 65: Diagnostic Test - Systemic Lupus Erythematous - Product Description
- Table 66: Insight ALK ECD Assay - Product Status
- Table 67: Insight ALK ECD Assay - Product Description
- Table 68: Insight DEPDC1 Screen Assay - Product Status
- Table 69: Insight DEPDC1 Screen Assay - Product Description
- Table 70: Insight ROS1 Fusion Screen Assay - Product Status
- Table 71: Insight ROS1 Fusion Screen Assay - Product Description
- Table 72: KIR/KIR-Ligand LDT Assay - Product Status
- Table 73: KIR/KIR-Ligand LDT Assay - Product Description
- Table 74: Lung Screening Assay - Product Status
- Table 75: Lung Screening Assay - Product Description
- Table 76: Next-Generation DetermaVu - Product Status
- Table 77: Next-Generation DetermaVu - Product Description
- Table 78: NGS Lung Panel Test - Product Status
- Table 79: NGS Lung Panel Test - Product Description
- Table 80: PanC-Dx - Bladder Cancer - Product Status
- Table 81: PanC-Dx - Bladder Cancer - Product Description
- Table 82: PanC-Dx - Breast Cancer - Product Status
- Table 83: PanC-Dx - Breast Cancer - Product Description
- Table 84: PanC-Dx - Breast Cancer - Clinical Study of PanC-Dx for Breast Cancer and Other Types of Human Cancers
- Table 85: PanC-Dx - Colon Cancer - Product Status
- Table 86: PanC-Dx - Colon Cancer - Product Description
- Table 87: PanC-Dx - Lung Cancer - Product Status
- Table 88: PanC-Dx - Lung Cancer - Product Description
- Table 89: PanC-Dx - Prostate Cancer - Product Status
- Table 90: PanC-Dx - Prostate Cancer - Product Description
- Table 91: Therapeutic Monitoring Test - Pancreatic Cancer - Product Status
- Table 92: Therapeutic Monitoring Test - Pancreatic Cancer - Product Description
- Table 93: Therasure Transplant Monitor Test - LDT - Product Status
- Table 94: Therasure Transplant Monitor Test - LDT - Product Description
- Table 95: Tumor Type 4 Assay - Product Status
- Table 96: Tumor Type 4 Assay - Product Description
- Table 97: OncoCyte Corp, Key Employees
- Table 98: OncoCyte Corp, Other Locations
- Table 99: OncoCyte Corp, Subsidiaries
- Table 100: Glossary
- List of Figures
- Figure 1: OncoCyte Corp Pipeline Products by Equipment Type
- Figure 2: OncoCyte Corp Pipeline Products by Development Stage
- Figure 3: OncoCyte Corp Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.